Search
for
Sort by
Research 661–690 of 1000+
- Novel cosmeceuticals from plants—An industry guided review
- Hair loss and herbs for treatment
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Experimental and Clinical Pharmacology of<i>Ziziphus jujuba</i>Mills
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- The Basic Science of Hair Biology
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Undariopsis peterseniana Promotes Hair Growth by the Activation of Wnt/β-Catenin and ERK Pathways
- Topically used herbal products for the treatment of hair loss: preclinical and clinical studies
- Guidelines for the Use of Acitretin in Psoriasis
- Recent Formulation Advances of Mangiferin
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- INTERFERONS IN DERMATOLOGY
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Androgenetic alopecia; drug safety and therapeutic strategies
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Teriflunomide in multiple sclerosis: an update
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period
- HAIR MATRIX CELL KINETICS: A SELECTIVE REVIEW
- Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Topical use of systemic drugs in dermatology: A comprehensive review
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- Spironolactone and XPB: An Old Drug with a New Molecular Target